168 filings
Page 2 of 9
6-K
ij65p37 0em0jlks9m6
18 Dec 23
CENTOGENE Announces Changes in Supervisory Board
6:41am
6-K
vlql6guqifk8h9
13 Dec 23
Current report (foreign)
6:33am
6-K
wo1g2be ss
1 Dec 23
Current report (foreign)
6:30am
6-K
x8d65u751rntr
28 Nov 23
CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction
6:30am
6-K
izjz1h v03mcng
3 Nov 23
Third Amendment to Loan and Security Agreement
4:30pm
6-K
g8cg70ec
27 Oct 23
Variation Agreement to Joint Venture Agreement
7:28am
6-K
emu72
10 Oct 23
CENTOGENE Expands Multiomic Diagnostic Portfolio With Newly-Launched Transcriptomic Offering
6:30am
6-K
s1yli58d
6 Oct 23
CENTOGENE Announces Changes in Supervisory Board
4:30pm
6-K
i0a3efpuy6rix rn18q
7 Sep 23
CENTOGENE Reports First Half 2023 Financial Results
5:00pm
6-K
b8v6o1 se
1 Sep 23
CENTOGENE Announces Publication Establishing Lyso-Gb1 as a Predictive Biomarker for Gaucher Disease Patients
8:00am
6-K
9ge2iq4z27zsxe6 ie9
31 Aug 23
CENTOGENE Receives Nasdaq Non-Compliance Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency
4:08pm
6-K
kudeqj79kdeej2
18 Aug 23
CENTOGENE Announces Change in Supervisory Board
4:30pm
6-K
dm5vjqf2 a8h
14 Jul 23
Current report (foreign)
6:31am
6-K
fc8br689 gdlj
12 Jul 23
Current report (foreign)
7:30am
6-K
5r8dayqx2pxr
30 Jun 23
CENTOGENE Announces Approval of All Resolutions Tabled at 2023 Annual General Meeting
4:31pm
6-K
dkuq9xok379hyp
27 Jun 23
Current report (foreign)
9:36am
6-K
2tt90z
14 Jun 23
CENTOGENE Receives Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency
4:33pm
6-K
4p01u
13 Jun 23
Current report (foreign)
6:00am
6-K
xibd2c2szcrwg4lc9x
19 May 23
Current report (foreign)
9:29am
IRAN
0145hyx
17 May 23
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
12:00am